NEW YORK (Reuters) - Drugmakers including Pfizer Inc <PFE.N>, GlaxoSmithKline PLC <GSK.L> and Sanofi SA <SASY.PA> are planning to hike U.S. list prices on more than 200 drugs in the United States ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results